Form fit function.png
Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation
February 15, 2023 16:15 ET | Conformis, Inc.
BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement...
Form fit function.png
Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022
February 10, 2023 07:00 ET | Conformis, Inc.
BILLERICA, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, provided today a...
Form fit function.png
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
January 23, 2023 16:30 ET | Conformis, Inc.
BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...
Form fit function.png
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
November 30, 2022 16:30 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Stock Market...
Form fit function.png
Conformis Announces First Procedure Performed Using New Actera™ Hip System
November 29, 2022 07:30 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced that...
Form fit function.png
Conformis Announces Full Commercial Launch of Imprint™
November 17, 2022 07:00 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the...
Form fit function.png
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
November 14, 2022 16:15 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Medacta USA, Medacta Germany GmbH,...
Form fit function.png
Conformis, Inc. Effects 1-for-25 Reverse Stock Split
November 09, 2022 07:00 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) (“Conformis”) announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today....
Form fit function.png
Conformis Reports Third Quarter 2022 Financial Results
November 02, 2022 16:10 ET | Conformis, Inc.
BILLERICA, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
October 05, 2022 16:30 ET | Conformis, Inc.
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...